Healthcare IT Managed Services Provider M&A Market Overview

In the mid-market healthcare IT M&A space, buyers are attracted to Managed Service Providers that demonstrate strong recurring revenue, high customer retention, and scalable B2B software solutions, particularly in areas like telehealth, remote patient monitoring, AI-driven analytics and diagnostics, EHR platforms, and digital health with interoperable platforms.

• Digital Health Solutions — Virtual care, remote monitoring, and predictive analytics platforms sought after for their potential to improve patient care and efficiency.
• AI and Machine Learning — AI-driven diagnostics, workflow automation, and generative AI for medical imaging analysis and automated documentation are highly attractive.
• Electronic Health Records (EHR) Platforms — Companies offering robust and interoperable EHR platforms remain a key target for buyers looking to integrate and expand their technology offerings.
• Interoperable Health Platforms — Digital health platforms that easily integrate with existing systems enable seamless data exchange and a more cohesive healthcare ecosystem.
• Specialized Clinical Tech — Companies focused on AI in diagnostics, surgical robotics, and AI-driven clinical workflow automation are in high demand.

Buyers are particularly interested in digital health platforms that improve virtual care, remote patient monitoring, and overall care delivery. These acquisitions are driven by the goal of making healthcare more efficient and effective.

RCM has been a strong segment for M&A activity, attracting attention from both financial and strategic buyers due to:

• Market fragmentation
• Easier sales cycles
• Outcome-based pricing models
• High demand from providers looking to improve their bottom line

There is significant buyer interest in healthcare IT companies with advanced technologies in artificial intelligence, machine learning, and data analytics. These technologies are seen as vital for:

• Improving predictive accuracy during due diligence
• Driving efficiencies in drug discovery
• Enhancing patient care management

Attractive targets include software solutions that address labor shortages, optimize care delivery, and improve overall workflows including:

• Pharmacy Software — Improves medication management and patient safety.
• B2B Solutions — Providers are driving demand for B2B solutions in practice management and RCM to navigate rising costs.

The expansion of virtual health services has made companies in this space common M&A targets. Examples include companies specializing in telepsychiatry and other telemedicine services that play a significant role in reducing costs and improving the patient experience.

• Recurring Revenue Models — MSPs with predictable, recurring revenue streams and high customer retention are especially attractive to investors.
• Consolidation and Scalability — Buyers often seek to consolidate the fragmented market, overcome talent constraints, and leverage synergies to expand into new markets.
• Faster Implementation — Acquiring existing technology assets is often faster than developing them in-house, accelerating speed-to-market.

• Recurring Revenue and Scalable Software — MSPs with consistent, recurring revenue streams and scalable software solutions, especially in the B2B vertical, are highly valued.
• Sticky Customers & High Retention — Strong customer retention rates indicate a stable customer base and higher customer lifetime value.
• Technological Advantage — Buyers are drawn to companies with cutting-edge technology and platforms that offer a competitive edge.
• Growth Potential — MSPs with clear opportunities for growth, such as geographic expansion or entering new customer segments, are attractive for their potential to generate high ROI.
• Experienced Management Teams — The expertise and experience of the management team are crucial, especially when private equity firms expect the leadership to remain post-acquisition.

N2M Advisory, our affiliate company, was founded as a healthcare technology advisory firm. We worked with entrepreneurs, physicians, scientists, venture capital firms and more — launching, assessing, scaling and turning around firms. N2M has over three decades of experience in deep healthcare and life sciences industry expertise in medical devices, pharmaceuticals and healthcare technology.

N2M Capital Advisors’ seasoned advisors have collectively advised on hundreds of transactions for a variety of clients including family-owned businesses, entrepreneur-led companies, public corporations and leading private equity firms — with over three decades of experience in healthcare and healthcare IT services.

N2M Capital Advisors has a long history of supporting leading private equity firms with buy-side and sell-side advisory, IT & cyber due diligence and post-deal value creation. Specialized Private Equity Services include:

• Pre-Deal Due Diligence
• Buy-Side Advisory
• Sell-Side Advisory
• IT & Cyber Due Diligence
• Exit Strategy Support
• Post-Deal Value Creation